椎管内吗啡在初次全关节置换术现代多模式镇痛中是否仍有作用
该回顾性研究纳入598例行初次全关节置换术并接受标准化多模式康复路径的患者,比较布比卡因椎管内麻醉联合椎管内吗啡(467例)与单用布比卡因椎管内麻醉(131例);椎管内吗啡组术后第0天疼痛评分更低、口服吗啡当量更少,术后第1天行走更远,住院期间术后恶心呕吐更少。
要点
- 椎管内吗啡组术后第0天视觉模拟评分均值1.5±1.6,低于对照组的2.5±1.9(P<.001)。
- 椎管内吗啡组术后第0天口服吗啡当量10.5±25.4,少于对照组的16.8±27.2(P=.013)。
- 椎管内吗啡组住院期间术后恶心呕吐发生率38.5%,低于对照组的48.6%(P=.043)。
核心结论
- 在现代区域麻醉与多模式镇痛康复方案下,椎管内吗啡仍可因其获益而被考虑。
研究设计与样本
- 回顾性研究,纳入接受标准化多模式康复路径的初次全关节置换术患者,比较布比卡因椎管内麻醉联合椎管内吗啡与单用布比卡因椎管内麻醉(对照)。
- 共纳入598例患者,其中对照组131例、椎管内吗啡组467例,两组人口学特征相似。
主要发现
- 术后第0天,椎管内吗啡组视觉模拟评分均值1.5±1.6,低于对照组的2.5±1.9(P<.001)。
- 术后第0天,椎管内吗啡组口服吗啡当量10.5±25.4,少于对照组的16.8±27.2(P=.013)。
- 至术后第1天,椎管内吗啡组行走距离133.6±159.6 m,远于对照组的97.3±141 m(P=.028)。
- 椎管内吗啡组整个住院期间术后恶心呕吐发生率38.5%,低于对照组的48.6%(P=.043)。
- 总吗啡当量消耗、出院至护理机构的比例、住院时长和90天再入院率均无显著差异。
临床怎么用
- 作者认为,在现代区域麻醉与多模式镇痛康复方案下,椎管内吗啡仍可因其获益而被考虑。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Intrathecal morphine (ITM) combined with bupivacaine spinal anesthesia can improve postoperative pain, but has potential side effects of postoperative nausea/vomiting (PONV) and pruritus. With the use of multimodal analgesia and regional anesthetic techniques, postoperative pain control has improved significantly to a point where ITM may be avoided in total joint arthroplasty (TJA). METHODS: We performed a retrospective study of primary TJA patients who underwent a standardized multimodal recovery pathway and received bupivacaine neuraxial anesthesia with ITM vs bupivacaine neuraxial anesthesia alone (control). RESULTS: In total, 598 patients were identified (131 controls, 467 ITMs) with similar demographics. On postoperative day 0 (POD 0), ITM patients had significantly lower mean visual analog scale scores (1.5 ± 1.6 vs 2.5 ± 1.9, P < .001) and consumed less oral morphine equivalents (10.5 ± 25.4 vs 16.8 ± 27.2, P = .013). ITM patients walked further compared to controls by POD 1 (133.6 ± 159.6 vs 97.3 ± 141 m, P = .028) and were less likely to develop PONV during their entire hospital stay (38.5% vs 48.6%, P = .043). No significant differences were seen for total morphine equivalents consumption, rate of discharge to care facility, length of stay, and 90-day readmission rates. CONCLUSION: ITM was associated with improved POD 0 pain scores and less initial oral/intravenous opioid consumption, which likely contributes to the subsequent improved mobilization and lower rates of PONV. In the setting of a modern regional anesthesia and multimodal analgesia recovery plan for TJA, ITM can still be considered for its benefits.
引用
- Cheah JW, Sing DC, Hansen EN, et al. Does Intrathecal Morphine in Spinal Anesthesia Have a Role in Modern Multimodal Analgesia for Primary Total Joint Arthroplasty? J Arthroplasty. 2018. PMID: 29433962. doi:10.1016/j.arth.2018.01.016
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。